The Meakins-Christie Laboratories is a leading pulmonary research centre located in Montreal (Canada) and affiliated with McGill University, one of the top ranked universities in the world. Our overall mission is to better understand the pathobiology of respiratory disorders across the lifespan. The ultimate goal of our efforts is to drive innovations in respiratory disease prevention, diagnosis, and therapy. Research is focused around five primary themes: Chronic Airways Disease, Lung Injury and Infection, Neuromuscular Dysfunction in Respiratory Diseases, Sleep-disordered Breathing, and Lung Cancer. Our faculty of world-class researchers work within the Translational Research in Respiratory Diseases Program at the Research Institute of the McGill University Health Centre.
Meakins-Christie Group Photo
The Meakins family is proud to stand alongside a diverse and dedicated research community, working together to advance knowledge and improve health.
Montreal Chest Institute Living Lab Personalized Medicine Initiative
Laboratoire vivant de l’Institut thoracique de Montréal Initiative de médecine personnalisée
In the News
Canada Research Chair in Trained Immunity
Maziar Divangahi appointed a new Canada Research Chair in Trained Immunity
Spring 2026 Student Awards
Congratulations to the 2026 recipients of FRQS and CIHR studentship and fellowship awards! We wish you much success!
2026-2027 FRQS Salary Awards
Congratulations to Nicole Li-Jessen for receiving her FRQS Senior salary award!
2026 RESP Research Day Poster and Oral Winners
Congratulations to all of our oral and poster presenter winners from the 2026 Respiratory Research Day
Early Career Researcher Awards in Asthma
Congratulations to Eva Kaufmann who received a competitive Early Career Research Award from CIHR-ICRH, CAAIF, Asthma Canada, and CLA.
CRBS-MI4 Blue-Sky Seed Funding Results
Dao Nguyen receives CRBS-MI4 Blue-Sky Seed Funding to study how Pseudomonas aeruginosa drives infection and treatment resistance
MI4-Pathy Seed Fund Grant Winners
Congrats to Irah King and Dao Nguyen who received MI4-Pathy Seed Funding in support of their innovative research in infection and antimicrobial resistance.
AI Tool Identifies Aggressive Cancer Cells
A new AI tool developed by Jun Ding identifies the most aggressive cancer cells and predicts patient outcomes.
Rethinking Tuberculosis Care in Nunavik: Inuit Voices Call for Change
New study by Faiz Ahmad Khan reveals how Inuit communities in Nunavik experience tuberculosis care and calls for more culturally safe, community-led approaches to improve outcomes.
Upcoming Events
36th Annual Doctor Dorothy Wiselberg Seminar
36th Annual Doctor Dorothy Wiselberg Seminar Friday, June 5, 2026. Keynote: Wim Janssens, MD, PhD, Universitair Ziekenhuis Leuven.
Christie Lecture 2026 – June 5, 2026
2026 Christie Lecture by Dr. Andrea Aliverti: Measuring breathing: from the lab to real life, in conjunction with the 36th Doctor Dorothy Wiselberg Seminar.
The 7th International Conference on Innate Immune Memory
The 7th International Conference on Innate Immune Memory September 23-25, 2026.
Work-in-Progress
May 25, 2026: Christina Shnaider and Alfredo Moreno Olmedo
May 25, 2026, at 9:00 am. Work-in-Progress: Christina Shnaider (MSc Grad Student with Bruce Mazer) and Alfredo Moreno Olmedo (PhD Grad Student with Darcy Wagner).
June 1, 2026: Sean Fletcher and Iran Augusto Neves da Silva
June 1, 2026, at 9:00 am. Work-in-Progress: Sean Fletcher (MSc Grad Student with Anne-Marie Lauzon) and Iran Augusto Neves da Silva (Post Doctoral Fellow with Darcy Wagner).
June 8, 2026: Israel Shpilman
June 8, 2026, at 9:00 am. Work-in-Progress: Israel Shpilman (PhD Grad Student with Bruce Mazer).